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During the last 25 years, display techniques such as
phage display have become very powerful tools for
protein engineering, especially for the selection of
monoclonal antibodies. However, while this method
is extremely efficient for affinity-based selections,
its use for the selection and directed evolution of
enzymes is still very restricted. Furthermore, phage
display is not suited for the engineering of mamma-
lian proteins that require posttranslational modifica-
tions such as glycosylation or membrane anchoring.
To circumvent these limitations, we have developed
a system in which structurally complex mammalian
enzymes are displayed on the surface of retroviruses
and encapsulated into droplets of a water-in-oil
emulsion. These droplets are made and manipulated
using microfluidic devices and each droplet serves
as an independent reaction vessel. Compartmentali-
zation of single retroviral particles in droplets allows
efficient coupling of genotype and phenotype. Using
tissue plasminogen activator (tPA) as a model
enzyme, we show that, by monitoring the enzymatic
reaction in each droplet (by fluorescence), quantita-
tive measurement of tPA activity in the presence of
different concentrations of the endogenous inhibitor
PAI-1 can be made on-chip. On-chip fluorescence-
activated droplet sorting allowed the processing of
500 samples per second and the specific collection
of retroviruses displaying active wild-type tPA from
a model library with a 1000-fold excess of retrovi-
ruses displaying a non-active control enzyme. During
a single selection cycle, a more than 1300-fold
enrichment of the active wild-type enzyme was
demonstrated.
INTRODUCTION
Display technologies such as phage display are widely used
techniques for protein engineering, allowing the selection and
evolution of protein variants with desired properties (Levin andChemistry & Biology 17, 2Weiss, 2006). In a typical phage display experiment, huge
numbers (up to 1010–1012) of protein variants are generated on
the genetic level and subsequently displayed fused to the coat
proteins of phage particles. Phage particles package the gene
encoding the protein variant displayed on their surface, which
allows coupling of genotype and phenotype to be achieved.
Subsequently these particles are subjected to a selection pro-
cedure (most commonly the binding to an immobilized tar-
get molecule). The power of this approach results from the
fact that the phage can be replicated to allow multiple rounds
of selection and directed evolution (if mutations are introduced
between the rounds of selection). Furthermore, the genera-
tion of the libraries, as well as the amplification/identification of
selected variants, can be performed using highly efficient
genetic methods. This not only allows the rapid generation of
billions of protein variants but also their selection and identifica-
tion at concentrations that are far below the detection level of
conventional methods in protein chemistry. These conceptual
advantages have also been exploited by further display methods
such as the display of proteins on the surface of bacteria (Fran-
cisco et al., 1993) or yeast cells (Boder and Wittrup, 1997) or
completely in vitro systems such as ribosome (Hanes and Pluck-
thun, 1997) and mRNA display (Roberts and Szostak, 1997),
where all steps of the selection procedure (including the protein
expression) can be performed without the need for any cell trans-
formation, thus allowing the screening of even more diverse
libraries.
Phage display has been successfully used for the selection of
therapeutic antibodies that are now in clinical use (e.g., the anti-
TNF-a antibody Humira). Furthermore, the method has proven to
be extremely powerful for the selection of other target-binding
molecules such as ankyrin repeat proteins (Binz et al., 2003)
and for the characterization of HIV protease cleavage sites
(Beck et al., 2000). Phage display has also been used for the
selection of proteins with catalytic activities. However, this appli-
cation requires a technique coupling a catalytic property with an
acquired binding activity. This can be achieved by displaying
enzyme variants on the phage particles and subsequently
selecting for binding to enzyme inhibitors or transition state
analogs (Soumillion et al., 1994; Hansson et al., 1997). Alterna-
tively, the enzyme and its substrate can be co-displayed on
the phage particle before selecting for product-specific adsorp-
tion to a solid support (Demartis et al., 1999). However, these
strategies and others generally do not allow the selection for
multiple turnover (Fernandez-Gacio et al., 2003). Therefore,29–235, March 26, 2010 ª2010 Elsevier Ltd All rights reserved 229
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at very slow turnover rates (e.g., due to inefficient product
release) are often selected (Vanwetswinkel et al., 2000). Conse-
quently, the selection of efficient catalysts remains problematic
when using phage particles.
Some cell-based strategies have been developed that allow
this limitation to be circumvented. For example, enzyme variants
can be displayed on the surface of the positively charged bacte-
rial membrane. Hence negatively charged reaction products
(generated from soluble fluorogenic substrates) attach to the
surface and can thus be used to quantitatively determine the
substrate turnover in fluorescence activated cell sorting experi-
ments (Olsen et al., 2000). Alternatively, covalent binding of the
fluorescent reaction product can be achieved when using
specific acceptor molecules on the cellular membrane of yeast
cells (Lipovsek et al., 2007). However, both strategies require
specific chemical labels for the attachment of the reaction
product (in addition to the fluorescent label) and are hence not
truly generic.
We present here a novel approach for the screening of
surface-displayed enzymes under multiple turnover conditions.
In this system, enzymes are displayed on the surface of the
murine leukemia virus (MLV) (Buchholz et al., 1998) and subse-
quently encapsulated into drops of a water-in-oil emulsion.
Earlier studies have shown that each droplet can serve as an
independent microreactor (Tawfik and Griffiths, 1998), allowing
the selection of RNAs and proteins for a range of binding,
regulatory, and catalytic activities (Griffiths and Tawfik, 2006).
For example, enzymes can be selected under multiple turnover
conditions using fluorogenic assays and sorting droplets trig-
gered on fluorescence using either conventional fluorescence
activated cell sorters (Mastrobattista et al., 2005; Aharoni et al.,
2005) or microfluidic devices (Baret et al., 2009). In our system,
we combine the power of microfluidic systems with eukaryotic
virus display, which allows the screening of structurally complex
proteins requiring disulfide bridging, glycosylation, and/or mem-
brane anchorage. As a model system, we chose human tissue
plasminogen activator (tPA), since this enzyme is of high thera-
peutic relevance (tPA is an emergency drug for deep vein
strokes) and requires posttranslational modifications for enzy-
matic activity (Walsh and Jefferis, 2006).
RESULTS
The goal of this work was the establishment of a novel method
suitable for the directed evolution of structurally complex mam-
malian enzymes under multiple turnover conditions. In general,
multiple turnover conditions can be achieved using in vitro
compartmentalization, a technique in which proteins are trans-
lated within aqueous droplets of a water-in-oil emulsion (Tawfik
and Griffiths, 1998). Each droplet then serves as an independent
reaction vessel, thus allowing the use of soluble substrates and
the selection for catalytic activity under multiple turnover con-
ditions. However, as with phage display, this method is not
well suited for mammalian enzymes like tPA, requiring com-
prehensive posttranslational modifications. The expression of
unglycosylated but active tPA under oxidizing conditions in the
periplasm of Escherichia coli has been demonstrated after coex-
pression of eukaryotic folding enzymes (Qiu et al., 1998).230 Chemistry & Biology 17, 229–235, March 26, 2010 ª2010 ElsevieHowever, we observed that in vitro-translated tPA is not active,
unless translated under oxidizing conditions with simultaneous
dialysis to allow disulfide bond formation (see Figure S1 available
online). This procedure cannot be performed in aqueous micro-
compartments, for which reason we chose a different expression
system. The MLV seemed to be perfectly suited since it allows
expression of secreted, disulfide bonded, and glycosylated
proteins in a eukaryotic context. To display the protein on the
particle surface, we fused it N-terminally to the platelet-derived
growth factor receptor transmembrane domain. Earlier studies
had shown that the resulting fusion proteins are incorporated
highly efficiently into MLV particles (Nikles et al., 2005). Further-
more, displaying the enzyme of interest directly on a nonviral
transmembrane domain instead of the viral envelope protein
rendered it resistant to shedding during particle concentration
(the viral envelope protein consists of two noncovalently linked
subunits partially dissociating during ultracentrifugation) (Yu and
Wong, 1992). To guarantee the coupling of genotype and pheno-
type, an MLV-packagable vector was used for the expression of
the fusion protein. Consequently, MLV particles displaying tPA
on their surface and having packaged the encoding vector
were obtained (MLV-tPA). For control purposes, we also gener-
ated particles displaying a non-related control enzyme (neur-
aminidase) and having packaged a distinguishable genetic
marker (MLV-NA).
In the next step, we focused on coupling a fluorescence signal
with catalytic activity. The reaction catalyzed by tPA is the
cleavage of inactive plasminogen into active plasmin. Hence
tPA activity can be monitored by either using a fluorescent tPA
substrate or by using a fluorescent substrate for plasmin (Fig-
ure 1). This latter approach seemed to be preferable, since it
allows screening using the physiological tPA substrate. Bulk
experiments (using a plate reader) confirmed that MLV-tPA parti-
cles indeed generated a strong fluorescence signal using this
assay. In contrast, the MLV-NA particles produced a very low
background signal, thus confirming the specific monitoring of
tPA activity (Figure S2). Noteworthy, when whole cells were
used in the assay (instead of purified MLV particles), the gener-
ation of a significant fluorescence signal did not depend on
the expression of tPA. Probably due to unspecific conversion
of the substrate by other cellular enzymes, even wild-type
HEK293T cells showed a significant fluorescence signal (Fig-
ure S2). This suggests that in vitro selection systems (such as
phage or retrovirus display) might be better suited for enzyme
evolution than their in vivo counterparts based on cell surface
display.
As the next step, we used a microfluidic device (Figure 2A)
to encapsulate the MLV-tPA particles together with all assay
components into aqueous droplets (volume = 12 pl) of a water-
in-oil emulsion. This step was performed in the presence of
different concentrations of the endogenous inhibitor PAI-1
(0.5–4 mg/ml). As an internal reference, we spiked each emulsion
additionally with droplets containing no inhibitor (produced by
the second drop maker on the device; Figure 2A). The resulting
emulsions were collected off-chip and incubated for 6 hr at
37C before they were reinjected into a readout module (Fig-
ure 2B). A laser beam was focused onto the channels and the
epifluorescence of each drop was recorded (processing 500
samples per second). As expected, we obtained three differentr Ltd All rights reserved
Figure 1. Assay for the Enzymatic Activity of tPA
(A) The enzyme is displayed on the surface of MLV particles and cleaves plas-
minogen into active plasmin, which in turn converts a non-fluorescent
substrate into a fluorescent product.
(B) Chemical structure of the substrate and the fluorescent product.
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emulsion: the most negative population corresponds to droplets
that do not host any MLV-tPA particle (to avoid multiple particles
per drop on average only one particle per three drops was
encapsulated), the population with an intermediate intensity
corresponds to drops hosting an MLV-tPA particle in the pres-
ence of the inhibitor, and the most positive population corre-
sponds to drops hosting an MLV-tPA particle in absence of
any inhibitor (additional drops from the second drop maker).
Having a defined positive and negative population for each emul-
sion allowed the fluorescence data of all samples to be normal-
ized, enabling quantitative analysis of inhibition. As expected,
increasing concentrations of PAI-1 resulted in decreasing fluo-
rescence signals (Figure 3A). Analysis of the kinetic data (using
GraphPad Prism) revealed an IC50 of 1.1 mg/ ml (Figure 3B),Chemistry & Biology 17, 2which is in good agreement with bulk control experiments per-
formed in a microplate reader (IC50 = 2.7 mg/ml; data not shown).
Furthermore, for all tested inhibitor concentrations, a peak well
separated from the positive and negative population was
obtained. This clearly demonstrates that this system is capable
of discriminating populations with only small differences in their
enzymatic activity.
In a further experiment we demonstrated the possibility of
specifically enriching particles displaying active enzyme vari-
ants. For this purpose we generated mixtures of MLV-tPA parti-
cles (active) and MLV-NA particles (inactive) in a ratio of 1:100
and 1:1000. Using a microfluidic device (Figure 2C) these particle
mixtures were encapsulated together with all assay components
at the single particle level (approximately one particle per three
drops). After 6 hr off-chip incubation at 37C, the emulsions
were reinjected into a microfluidic device designed for dielectro-
phoretic sorting of droplets (Ahn et al., 2006; Baret et al., 2009)
(Figure 2D) and the fluorescence intensity of each drop was
determined. For both mixtures, two distinct populations were
obtained corresponding to empty droplets or droplets hosting
MLV-NA particles (negative population) and droplets hosting
MLV-tPA particles (positive population; Figure 4). In both the
1:100 and 1:1000 mixtures the percentage of positive drops
was very close to that expected (1.3% and 0.3% of all drops,
respectively; on average less than 7.5% of the droplets had coa-
lesced) (Figures 4B and 4C). The sorting gates (red rectangles in
Figures 4B and 4C) were set to include solely high fluorescence,
non-coalesced drops (coalesced drops show a higher peak
width and can therefore be excluded). The definition of the
peak width (the time a fluorescence signal is above a certain
threshold) results in highly fluorescent (positive) drops appearing
slightly bigger than low fluorescence (negative) drops. However,
this phenomenon is well understood and does not interfere with
the gating for non-coalesced positive drops (Clausell-Tormos
et al., 2008). Droplets flowed down the wider ‘‘negative’’ arm of
the sorting junction by default due to its lower hydraulic resis-
tance. However, when a droplet fell in the sorting gate, a pulse
of high-voltage alternating current was applied across the elec-
trodes adjacent to the sorting junction. The resulting electric field
deflected the droplet of interest into the narrower ‘‘positive’’ arm
of the junction by dielectrophoresis (Baret et al., 2009). For both
mixtures, approximately 3500 positive droplets were collected.
Based on the genetic markers of the two particle species
(MLV-tPA and MLV-NA), we quantitatively determined the sort-
ing efficiency. For this purpose, we took samples of our emulsi-
fied particle mixtures (MLV-tPA and MLV-NA in a ratio of 1:100
and 1:1000) before and after sorting, recovered the virally
packaged RNA, and performed a reverse transcription step.
The resulting cDNA was subsequently quantified by real-time
PCR (Figure 4D). Although before the sorting step the ratio of
MLV-tPA/MLV-NA cDNA was only 4.4:100 (1:100) and 0.5:100
(1:1000), after sorting, this ratio increased to 7.9:1 (1:100) and
8.3:1 (1:1000). This corresponds to enrichment factors of 172-
fold (1:100) and 1383-fold (1:1000) during a single selection
round. The higher enrichment observed with the 1:1000 mixture
is consistent with the previous observation that the sorter has
a very low false positive error rate (<1 in 104 droplets) and that
the primary limit to enrichment is co-encapsulation (of viral parti-
cles in this case) in droplets (Baret et al., 2009): the predicted29–235, March 26, 2010 ª2010 Elsevier Ltd All rights reserved 231
Figure 2. Microfluidic Devices
(A) Twin drop maker for the generation of emulsions with two
different droplet species (±inhibitors).
(B) Reinjection device for fluorescence measurements.
(C) Drop maker for the encapsulation of particle mixtures.
(D) Sorting device. The geometry of the sorting module was
calculated as described previously (Baret et al., 2009). Green
spots indicate the focus of the laser beam for the fluorescence
measurements. Colored rectangles indicate the sections
shown in the microscopic images. On-chip filters are located
after each inlet on all devices (Figure S4).
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fold and 3033-fold for the 1:100 and 1:1000 dilution, respec-
tively, and are thus only 2-fold higher than the experimentally
observed enrichments. In general, higher enrichments are
observed when the ratio of positive to negative particles is low.
Furthermore, the reduction of the average number of particles
per droplet to below 0.3 should allow higher enrichments at the
expense of lower throughput (Baret et al., 2009).
As an alternative strategy to the amplification of virally pack-
aged genes by RT-PCR, we also assessed the transduction of
host cells and subsequent amplification based on cell prolifera-
tion. For this purpose we generated tPA particles co-displaying
the G protein of the vesicular stomatitis virus (VSV-G) on their
surface. While this did not significantly alter the enzymatic
activity, it enabled the efficient transduction of HEK293T cells
(titer of 1.3 3 105 ± 9.9 3 103 i.U./ml). This approach should
enable the initiation of a further selection cycle after the sorting
step without the need for any subcloning, as with phage display
and cell surface display technologies: transduced cells can
be selected specifically by puromycin treatment (a resistance
to this antibiotic is encoded on the viral vector) before being
transfected with plasmids encoding the viral core proteins
(to generate new particles displaying the selected enzymes).
This should be useful for the screening of diverse enzyme
libraries, allowing several selection rounds to be performed
rapidly and consecutively.232 Chemistry & Biology 17, 229–235, March 26, 2010 ª2010 Elsevier Ltd All rightsDISCUSSION
We present here a novel approach for high-
throughput screening of displayed enzymes. This
method allows the selection of active variants
under multiple turnover conditions, including
eukaryotic enzymes that require complex post-
translational modifications.
Displaying the enzyme of interest, tPA, on MLV
particles not only ensured its expression in a
eukaryotic context but also allowed highly efficient
incorporation. Comparing the enzymatic activity of
MLV-tPA at a defined particle titer (as determined
during the encapsulation experiments) with that
of soluble recombinant enzyme leads to the con-
clusion that, on average, 818 tPA molecules were
displayed on the surface of each virion (Supple-
mental Information S5). Hence our display con-
struct showed incorporation rates similar to that
of homologous envelope proteins, of which nor-mally several hundred are present on the particle surface (Bach-
rach et al., 2000; Chertova et al., 2002). In contrast, usually no
more than one to five copies of an enzyme can be displayed
on phage particles (Fernandez-Gacio et al., 2003), for which
reason the MLV system used here seems to be beneficial.
The size of libraries that can be screened is, however, a limiting
factor. For non-replication competent MLV particles, mutated
libraries comprising 106 protein variants have been described
(Merten et al., 2006, 2005; Tolstrup et al., 2001), and a library
of this diversity would take 2 hr to screen using the microflui-
dics system described here. This is significantly less than what
can be selected using phage display (up to 1012 variants) (Levin
et al., 2006). Furthermore, the display of intracellular proteins on
the surface of retroviruses has not yet been shown. However,
this is most likely not a fundamental problem, but rather due to
the fact that, to date, the generation of retroviral display libraries
was mainly focusing on the engineering of viral envelope proteins
with improved host cell tropisms for gene therapy purposes
(Buchholz et al., 2008).
A strong advantage of the MLV system in comparison with
cell-based eukaryotic display systems [e.g., yeast cell surface
display (Shusta et al., 1999)] is that the enzyme of interest can
be screened in absence of cellular enzymes (potentially causing
significant background activities). MLV consists of just eight
different proteins, thus minimizing the chance for any undesired
background activities. Indeed, tPA-negative particles (MLV-NA)reserved
Figure 3. Fluorescence Signals of Droplets Con-
taining MLV-tPA Particles in the Presence of
Different Concentrations of the Endogenous Inhib-
itor PAI-1 (mg/ml)
(A) For each inhibitor concentration, three different droplet
species were generated: empty droplets (lowest fluores-
cence; top left), droplets containing MLV-tPA in presence
of the indicated inhibitor concentration (intermediate
fluorescence; top center and highlighted by blue frames),
and droplets containing MLV-tPA in absence of any inhib-
itor (highest fluorescence; top right). All fluorescence
signals were normalized in respect to the droplets contain-
ing MLV-tPA in the absence of any inhibitor (highest fluo-
rescence). The fluorescence signal (x axis, logarithmic
scale) and the percentage of events (y axis) are shown
for each inhibitor concentration.
(B) Mean enzymatic activity (y axis) from three indepen-
dent experiments for each inhibitor concentration (x axis)
(calculated using the mean activity from each independent
experiment). The error bars correspond to the standard
deviation of the mean. The IC50 concentration was calcu-
lated using non-linear regression to fit the four parameter
Hill Equation using GraphPad Prism.
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whereas tPA-negative cells (HEK293T) generated significant
fluorescence (S2).
In general, our method should be of special interest for the
optimization of mammalian enzymes in clinical use, such as
anticoagulants (tPA and urokinase), enzymes in cancer therapy
(pegaspargase and rasburicase), or enzymes for the treatment
of genetic diseases (pegademase, alglucerase, and dornase a).
In contrast to conventional display techniques, the compart-
mentalization approach allows screens to be performed under
multiple turnover conditions and enables the use of soluble
substrates and products. Especially when using microfluidic
devices for the generation and sorting of droplets, this approach
seems to be extremely powerful. First, the droplets generated
using microfluidic devices are highly monodisperse, allowingChemistry & Biology 17, 229–235, March 26quantitative measurements as demonstrated
here (the IC50 of the tPA inhibitor PAI-1 mea-
sured in droplets and in microtiter plates was
almost identical). Second, fluorescence-acti-
vated droplet sorting in microfluidic systems
has a very low sorting error rate (<104) and
can be performed at rates of up to two kilohertz
(Baret et al., 2009).
Quantitative enzyme screens can also be
performed under multiple turnover conditions
in microtiter plates; however, time and cost
considerations generally limit the number of
variants that can be screened to 103–105. Even
using sophisticated robots, it is only possible
to process 100,000 assays a day, or 1 per
second, and it is difficult to reduce the assay
volume below 1 ml due to problems related to
evaporation and capillary forces (Dove, 1999).
In contrast, the droplet-based system allows
the quantitative analysis of up to 500 sam-
ples per second (corresponding to 4.3 3 107samples per day), a throughput over 100 times higher than
with microtiter plates. Furthermore, the assay miniaturization
gives rise to massively reduced screening costs. When using
12 pl droplets (as demonstrated here), the assay volumes are
decreased approximately 106-fold in comparison to microtiter
plates (assuming an assay volume of 10 ml). This means that
the consumables cost for screening 107 tPA variants is reduced
from at least $4,500,000 to only $5.2, a nearly 106-fold reduction
(Supplemental Information S6).
SIGNIFICANCE
This manuscript describes a microfluidic approach for the
screening of structurally complex enzyme variants. Similar
to phage display, the enzyme variants are displayed on the, 2010 ª2010 Elsevier Ltd All rights reserved 233
Figure 4. Specific Sorting of Particles Displaying Active Enzyme
Variants
MLV-tPA and MLV-NA particles were mixed, encapsulated, and subjected to
fluorescence-activated droplet sorting.
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234 Chemistry & Biology 17, 229–235, March 26, 2010 ª2010 Elseviesurface of viral particles. However, by using a mammalian
expression system and encapsulating the resulting viral
particles into tiny droplets (picoliter volumes), our approach
enables the screening of structurally complex enzymes (e.g.,
requiring glycosylation and/or membrane anchorage) under
multiple turnover conditions. In comparison to conventional
screening formats such as microtiter plates, our system
allows more than 100-fold increased throughput and almost
one million-fold reduced consumables costs (due to the tiny
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